지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Spontaneous regression of hepatocellular carcinoma (HCC) is extremely rare, and dozens of cases have been reported in theliterature. In this report, we present a case of pathologically confirmed HCC that partially regressed without medical intervention. A54-year-old Korean male with chronic hepatitis B had a hepatic mass detected by abdominal ultrasonography during a routine visit.
A clinical diagnosis of HCC was made after measuring serum α-fetoprotein levels followed by dynamic computedtomography and magnetic resonance imaging. The patient delayed surgical resection; however, after 5 months, the size of theHCC decreased from 3.2 to 1.0 cm in diameter without any treatment. At that time the mass was surgically resected. Histopathologyconfirmed that the hepatic mass was consistent with partially regressed HCC and showed more intra- and peri-tumoral lymphocytesconsisting of greater CD4+ T cell infiltration than what is normally seen in resected HCC.
목차
등록된 정보가 없습니다.
참고문헌 (10)
참고문헌 신청
/ 2011 / Korea National Health and Nutrition Examination Survey
Bruix J / 2011 / American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update / Hepatology 53 : 1020 ~ 1022
Fu J / 2013 / Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma / Hepatology 58 : 139 ~ 149
Homma S / 2005 / Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine a
Lee HS / 2000 / Recurrent hepatocellular carcinoma after spontaneous regression / J Gastroenterol 35 : 552 ~ 556
Bruix J / 2011 / American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update / Hepatology 53 : 1020 ~ 1022
Fu J / 2013 / Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma / Hepatology 58 : 139 ~ 149
Homma S / 2005 / Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine a
Lee HS / 2000 / Recurrent hepatocellular carcinoma after spontaneous regression / J Gastroenterol 35 : 552 ~ 556
이 논문의 저자 정보
최근 본 자료
댓글(0)
0